Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma.

Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma.

http://www.wikidata.org/entity/Q36444733

about

Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome Molecular targets of aspirin and cancer prevention.Exercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic Injury Alleviating Promotion of Inflammation and Cancer Induced by Nonsteroidal Anti-Inflammatory Drugs Aspirin regulation of c-myc and cyclinD1 proteins to overcome tamoxifen resistance in estrogen receptor-positive breast cancer cells.Index-based dietary patterns and risk of incident hepatocellular carcinoma and mortality from chronic liver disease in a prospective study.Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis.Aspirin and salicylic acid decrease c-Myc expression in cancer cells: a potential role in chemoprevention.Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer.Association study of two inflammation-related polymorphisms with susceptibility to hepatocellular carcinoma: a meta-analysis.Non-steroidal anti-inflammatory drugs use is associated with reduced risk of inflammation-associated cancers: NIH-AARP study Association between C-reactive protein, incident liver cancer, and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study.Chemopreventive strategies in hepatocellular carcinoma Statin use and risk of primary liver cancer in the Clinical Practice Research Datalink.Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties.Circulating Tumor Cell Analyses in Patients With Esophageal Squamous Cell Carcinoma Using Epithelial Marker-Dependent and -Independent Approaches A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma.NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project.Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability.The aspirin-induced long non-coding RNA OLA1P2 blocks phosphorylated STAT3 homodimer formation.Menopausal hormone therapy use and risk of primary liver cancer in the clinical practice research datalink.LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway Cyclin A2 and CDK2 as Novel Targets of Aspirin and Salicylic Acid: A Potential Role in Cancer Prevention.Dietary fatty acids and risk of hepatocellular carcinoma in the Singapore Chinese health study.AMPK-mediated up-regulation of mTORC2 and MCL-1 compromises the anti-cancer effects of aspirin.Aspirin in combination with TACE in treatment of unresectable HCC: a matched-pairs analysis.Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection.Is Hepatocellular Cancer the Same Disease in Alcoholic and Nonalcoholic Fatty Liver Diseases?Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.Nonselective inhibition of prostaglandin-endoperoxide synthases by naproxen ameliorates acute or chronic liver injury in animals.Spontaneous regression of hepatocellular carcinoma in a Caucasian male patient: A case report and review of the literature Chronic hepatitis B: role of anti-platelet therapy in inflammation control.Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment.The cheating liver: imaging of focal steatosis and fatty sparing.Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma.Aspirin minimized the pro-metastasis effect of sorafenib and improved survival by up-regulating HTATIP2 in hepatocellular carcinoma.Adjuvant Medications That Improve Survival after Locoregional Therapy.Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection.Inflammation and cancer: inhibiting the progression of residual hepatic VX2 carcinoma by anti-inflammatory drug after incomplete radiofrequency ablation.

P2860

Q27319760-E3C62848-E2D3-44D7-B921-63522FB05817 Q27687847-C7791E10-C3AC-43DC-A5FB-37E51527913C Q28072762-C9FC20B6-265B-4E79-9877-A4F4241F6BC9 Q30234292-C3967BCB-2D46-473E-B656-A26F218A49EA Q33728292-CDD51D34-9E85-4F77-9B61-A3CF3835A771 Q33946524-E60BFF80-03EF-48F8-B846-E6EAB4CCF1F5 Q34351552-7193DDC3-83C8-4A17-8A57-38048F35225D Q34491262-F4DC7A5A-B233-4FA7-81F9-EC728D4E7428 Q34511085-4A4317A1-6D6A-445F-AA17-C24D148E7444 Q34537824-C9502C27-4C4F-41B8-BE8F-DA34DA539B8A Q34797536-4F73BB0F-9AF5-4140-844E-B1DFE3FCDDF4 Q35071202-629A6876-1B79-4D00-98DD-44D8F9A46046 Q35101365-D08B6CB8-BAB3-4EF0-8E5A-2F88AAA9441D Q35152907-F59B89E5-5EF0-4442-B02C-A22390EAC983 Q35619104-FB8571CA-F0DF-459D-B17B-B81823165ED8 Q36017220-21C278B3-3F96-444F-8519-3CB72B190258 Q36255936-5BFC664C-F5CE-4713-A8C6-F326B768F1A1 Q36291996-A7849D98-D796-4CEE-9F5F-3E3079D2EA88 Q36439797-029D4926-6E96-4476-9E11-D24BA6F53A80 Q36461735-047E117F-56C5-45F0-B926-4DAF7B6416DE Q36603129-FB38904A-E8B1-4A19-93F7-FACAC2FDD329 Q36609598-264FCC38-4AD6-4485-BB9B-51C3B52ACA8A Q36619028-42D5519E-1C60-405D-9C5B-CFA40E9D88BA Q36693257-037355B6-F8BB-47F0-B2B0-2757FD398693 Q36777552-3CEE7409-30AB-45BF-ADDC-016E494768F2 Q37086032-979173BE-9026-475D-B4A8-9661AF6A3F92 Q37298338-4BAA6D39-7A53-464D-B5A8-642B73849068 Q37408920-3689985C-1E7C-4126-BDFD-D6FFC30CA34E Q37432586-08E741E2-63BA-4EDE-959E-F5981B8A46F7 Q37584843-1C2AF4A0-612E-444F-A65E-22B6B8B368A6 Q37621796-7376553D-6E95-4D43-A9A2-5BF439942169 Q37701757-66CF88BD-92B6-402C-A0EF-AE04ACCC83C3 Q38314202-E8E3327D-80B9-4F9A-9A33-A32139D71E57 Q38724288-E722908E-2FE9-4A60-85E7-9C0C45D4EC53 Q38793475-0D24479B-6120-494B-AD68-A1ACD9E0E3BC Q38923529-420FC5B0-B85F-4778-B9FF-415E0B41A86D Q39143287-77320AEB-A729-4C44-B0D1-D428D9F9EEAE Q39319921-7F10BAAA-E4A1-4A8A-BF52-51497CD5EDB1 Q39473320-3F2E93D0-AD9E-4B17-B927-5C05AFD59540 Q40044969-7C494BDC-174C-4EA1-986A-C8B70E1659EC

P2860

Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma.

http://www.wikidata.org/entity/Q36444733

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Nonsteroidal anti-inflammatory ...... and hepatocellular carcinoma.

@ast

Nonsteroidal anti-inflammatory ...... and hepatocellular carcinoma.

@en

type

label

Nonsteroidal anti-inflammatory ...... and hepatocellular carcinoma.

@ast

Nonsteroidal anti-inflammatory ...... and hepatocellular carcinoma.

@en

prefLabel

Nonsteroidal anti-inflammatory ...... and hepatocellular carcinoma.

@ast

Nonsteroidal anti-inflammatory ...... and hepatocellular carcinoma.

@en

P1433

Q36444733-87EBB6B7-3288-4F05-8F12-0B155C645249

P1476

Q36444733-666DDD71-7C73-4834-BA88-FD83D72B5F2E

P2093

Q36444733-0A5B1DA5-744F-4997-A0BC-C4B1A45CD4E3

Q36444733-62876AFD-19A3-40ED-9481-0F5DF1EF828D

Q36444733-6F8983EC-F4CA-492F-8B64-FDCC870CC2C4

Q36444733-74016294-7CE5-4630-AD57-B44DC7C39B73

Q36444733-BED7172B-BA73-4678-A96C-D0417BF78A8B

Q36444733-C553989D-E169-4B97-8C1A-3217524261BB

Q36444733-E05C3DA4-25B8-4027-9DE8-4D21DCD84501

Q36444733-EA6FD32C-C9B9-4FED-B391-4C0F092F0242

P2860

Q36444733-022666AE-B1E0-44FE-8089-A4032E0C10EE

Q36444733-03C9B56F-CD12-4384-8579-0268C25F1616

Q36444733-085BA0C3-4888-4FF1-B67E-8210F9AC8970

Q36444733-1608EF6F-263F-4B70-B845-1D0050451BE9

Q36444733-17DCEBC3-845E-4ACB-8759-83AA5A5598AE

Q36444733-1F4805DC-9D2B-4FF6-BB72-FAAEEE0AF540

Q36444733-2B519CA0-4C62-4698-A896-6B2B32BD6D78

Q36444733-32D925D3-D75D-42E2-A6F1-DA352CEC0011

Q36444733-384046F4-901B-4C2E-8B7A-4DFBA744E912

Q36444733-3907C879-FB64-4165-95DB-C88F34F8B942

P304

Q36444733-34C0A3D4-74A9-4B51-9732-F865381D24D7

P31

Q36444733-BFCCD185-93BD-4522-BDF6-720133C2764C

P356

Q36444733-59EA5A69-7D91-43BD-A0C8-648A29D570EA

P407

Q36444733-08C12FFD-AB14-40EC-AC12-5462092275BD

P433

Q36444733-5CD1B1BC-399D-41E9-9737-D0F95934F5E1

P478

Q36444733-282ECB15-98F1-4D24-80FB-CA6836DE733D

P50

Q36444733-2B956644-B8DA-4C69-A996-EF62C7ADB9C8

P577

Q36444733-37D83D83-A65B-4E4B-90F5-53E443FAF82F

P698

Q36444733-CCAAB6CA-E289-42CC-96CB-74E86B8857EA

P921

Q36444733-47ED1FCF-7781-43D8-A0F9-28066B3B5A8A

P932

Q36444733-D9598DE9-0114-441C-8CBE-C9D6F94B664B

P356

P1433

Journal of the National Cancer Institute

P1476

Nonsteroidal anti-inflammatory ...... and hepatocellular carcinoma.

@en

P2093

Albert R Hollenbeck

http://www.w3.org/2001/XMLSchema#string

Barry I Graubard

http://www.w3.org/2001/XMLSchema#string

Britton Trabert

http://www.w3.org/2001/XMLSchema#string

Katherine A McGlynn

http://www.w3.org/2001/XMLSchema#string

Lauren M Schwartz

http://www.w3.org/2001/XMLSchema#string

Munira Z Gunja

http://www.w3.org/2001/XMLSchema#string

Neal D Freedman

http://www.w3.org/2001/XMLSchema#string

Vikrant V Sahasrabuddhe

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview

A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity

Immunity, Inflammation, and Cancer

The global epidemiology of hepatocellular carcinoma: present and future

Hepatocellular carcinoma

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

Aspirin and cancer risk: a quantitative review to 2011.

Correlation between expression of cyclooxygenase-2 and the presence of inflammatory cells in human primary hepatocellular carcinoma: possible role in tumor promotion and angiogenesis.

Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis.

P304

1808-1814

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJS452

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23197492

http://www.w3.org/2001/XMLSchema#string

P921

P932

3514167

http://www.w3.org/2001/XMLSchema#string